|
| 36325747 | Implications of worsening renal function before hospitalization for acute heart failure. | ESC Heart Fail | 2023 |
| 37286262 | Hemodynamic-Guided Heart Failure Management in Patients With Either Prior HF Hospitalization or Elevated Natriuretic Peptides. | JACC Heart Fail | 2023 |
| 37127240 | The Influence of Body Mass Index on Clinical Interpretation of Established and Novel Biomarkers in Acute Heart Failure. | J Card Fail | 2023 |
| 36332898 | Galectin-3, Acute Kidney Injury and Myocardial Damage in Patients With Acute Heart Failure. | J Card Fail | 2023 |
| 34324643 | Artificial intelligence: the pathway to the future of cardiovascular medicine. | Eur Heart J | 2022 |
| 35843615 | Finding acute coronary syndrome with serial troponin testing for rapid assessment of cardiac ischemic symptoms (FAST-TRAC): a study protocol. | Clin Exp Emerg Med | 2022 |
| 35377184 | Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis. | J Am Heart Assoc | 2022 |
| 36741100 | Natriuretic Peptide-guided Therapy for Heart Failure. | Heart Int | 2022 |
| 36456072 | Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status. | JACC Heart Fail | 2022 |
| 36456066 | Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial. | JACC Heart Fail | 2022 |
| 36103292 | Comparative Effect of Angiotensin Receptor Neprilysin Inhibition on B-type Natriuretic Peptide Levels Measured by Three Different Assays: The PROVE-HF Study. | Clin Chem | 2022 |
| 36155327 | Growth hormone concentration and risk of all-cause and cardiovascular mortality: The REasons for Geographic And Racial Disparities in Stroke (REGARDS) study. | Atherosclerosis | 2022 |
| 35880560 | Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndrome. | Coron Artery Dis | 2022 |
| 35040931 | Acute Heart Failure in the 2021 ESC Heart Failure Guidelines: a scientific statement from the Association for Acute CardioVascular Care (ACVC)Â of the European Society of Cardiology. | Eur Heart J Acute Cardiovasc Care | 2022 |
| 35202737 | Decongestion, kidney injury and prognosis in patients with acute heart failure. | Int J Cardiol | 2022 |
| 35266003 | The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic. | Eur Heart J | 2022 |
| 34697635 | Machine learning with D-dimer in the risk stratification for pulmonary embolism: a derivation and internal validation study. | Eur Heart J Acute Cardiovasc Care | 2022 |
| 32960964 | Development, validation, and implementation of biomarker testing in cardiovascular medicine state-of-the-art: proceedings of the European Society of Cardiology-Cardiovascular Round Table. | Cardiovasc Res | 2021 |
| 33788989 | Decongestion discriminates risk for one-year mortality in patients with improving renal function in acute heart failure. | Eur J Heart Fail | 2021 |
| 33617811 | Relation of Decongestion and Time to Diuretics to Biomarker Changes and Outcomes in Acute Heart Failure. | Am J Cardiol | 2021 |
| 33617307 | Response by Horiuchi et al to Letter Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction". | Circulation | 2021 |
| 34498368 | Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC). | Eur J Heart Fail | 2021 |
| 34401870 | Artificial intelligence MacHIne learning for the detection and treatment of atrial fibrillation guidelines in the emergency department setting (AIM HIGHER): Assessing a machine learning clinical decision support tool to detect and treat non-valvular atrial fibrillation in the emergency department. | J Am Coll Emerg Physicians Open | 2021 |
| 34461042 | Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. | Lancet | 2021 |
| 34600979 | Associations of cardiac injury biomarkers with risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis. | Int J Cardiol | 2021 |
| 34390682 | Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome. | Am J Med | 2021 |
| 34593206 | The Reply. | Am J Med | 2021 |
| 34251893 | Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF. | Circulation | 2021 |
| 34350422 | Stethoscope hygiene: A legal consideration for cardiologists practicing in a new era of infection control (COVID-19). | Am Heart J Plus | 2021 |
| 33977287 | Advancements in biomarkers for cardiovascular disease: diagnosis, prognosis, and therapy. | Fac Rev | 2021 |
| 33998243 | Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction. | Circ Heart Fail | 2021 |
| 33309581 | Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes. | JACC Heart Fail | 2021 |
| 33189632 | Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction. | JACC Heart Fail | 2021 |
| 33189630 | Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction. | JACC Heart Fail | 2021 |
| 33296713 | Potential Utility of Cardiorenal Biomarkers for Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure. | J Card Fail | 2021 |
| 31618697 | Clinical Characteristics and Outcomes of Patients With Heart Failure and Methamphetamine Abuse. | J Card Fail | 2020 |
| 31789688 | Cardiovascular health of nonagenarians in southern Italy: a cross-sectional, home-based pilot study of longevity. | J Cardiovasc Med (Hagerstown) | 2020 |
| 31903729 | Sacubitril-Valsartan in a routine community population: attention to volume status critical to achieving target dose. | ESC Heart Fail | 2020 |
| 32055768 | Aseptic Barriers Allow a Clean Contact for Contaminated Stethoscope Diaphragms. | Mayo Clin Proc Innov Qual Outcomes | 2020 |
| 31863682 | Short-term prognostic implications of serum and urine neutrophil gelatinase-associated lipocalin in acute heart failure: findings from the AKINESIS study. | Eur J Heart Fail | 2020 |
| 31833168 | Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACTâ¿¿EU Biomarkers in Cardiology (BIC) 18. | Eur J Heart Fail | 2020 |
| 32106929 | N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]). | Am J Cardiol | 2020 |
| 33045743 | The stethoscope: a potential vector for COVID-19? | Eur Heart J | 2020 |
| 32946164 | Sex-based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan. | Eur J Heart Fail | 2020 |
| 32654354 | Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities. | Eur J Heart Fail | 2020 |
| 32949178 | Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real-world population. | Clin Cardiol | 2020 |
| 32462801 | Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis. | ESC Heart Fail | 2020 |
| 32569591 | Persistent Value of the Stethoscope in the Age of COVID-19. | Am J Med | 2020 |
| 32482089 | Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan. | Circ Heart Fail | 2020 |
| 31369724 | The Impact of Substance Abuse on Heart Failure Hospitalizations. | Am J Med | 2020 |